首页> 外国专利> Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)

Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)

机译:缺氧诱导蛋白2(hig2),肾细胞癌(rcc)的新型治疗潜在目标

摘要

The present invention provides a method for inhibiting growth of a cancer cell, particularly a renal cell carcinoma, by contacting the cell with a composition composed of an HIG2 siRNA or HIG2 antibody. Methods of diagnosing renal cell cancer are also provided within the present invention.
机译:本发明提供了通过使癌细胞与由HIG2 siRNA或HIG2抗体组成的组合物接触来抑制癌细胞,特别是肾细胞癌的生长的方法。本发明内还提供了诊断肾细胞癌的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号